Literature DB >> 10549293

Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane.

A L Wu1, J Wang, A Zheleznyak, E J Brown.   

Abstract

Integrin-associated protein (IAP, CD47) is a plasma membrane receptor for thrombospondins and signal regulatory proteins (SIRPs) that has an essential role in host defense through its association with integrins. The IAP gene encodes alternatively spliced carboxyterminal cytoplasmic tails that have no previously described function. IAP cytoplasmic tails can bind two related proteins that mediate interaction between IAP and vimentin-containing intermediate filaments, named proteins linking IAP with cytoskeleton (PLICs). Integrins interact with PLICs indirectly, through IAP. Transfection of PLICs induces redistribution of vimentin and cell spreading in IAP-expressing cells. This novel connection between plasma membrane and cytoskeleton is likely to be significant in many adhesion-dependent cell functions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10549293     DOI: 10.1016/s1097-2765(00)80212-9

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  51 in total

Review 1.  Mechanisms of GABAA receptor assembly and trafficking: implications for the modulation of inhibitory neurotransmission.

Authors:  Josef T Kittler; Kristina McAinsh; Stephen J Moss
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

2.  Vimentin filaments in fibroblasts are a reservoir for SNAP23, a component of the membrane fusion machinery.

Authors:  W Faigle; E Colucci-Guyon; D Louvard; S Amigorena; T Galli
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

3.  Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy.

Authors:  Cara Rothenberg; Deepa Srinivasan; Leann Mah; Susmita Kaushik; Corrine M Peterhoff; Janet Ugolino; Shengyun Fang; Ana Maria Cuervo; Ralph A Nixon; Mervyn J Monteiro
Journal:  Hum Mol Genet       Date:  2010-06-07       Impact factor: 6.150

Review 4.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

5.  Ubiquilin interacts and enhances the degradation of expanded-polyglutamine proteins.

Authors:  Hongmin Wang; Mervyn J Monteiro
Journal:  Biochem Biophys Res Commun       Date:  2007-06-25       Impact factor: 3.575

6.  Screening for novel binding proteins interacting with human papillomavirus type 18 E6 oncogene in the Hela cDNA library by yeast two-hybrid system.

Authors:  Shuang Li; Ping Liu; Ling Xi; Xuefeng Jiang; Jianfeng Zhou; Shixuan Wang; Li Meng; Yunping Lu; Ding Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

Review 7.  Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication.

Authors:  Emily Cousins; John Nicholas
Journal:  Recent Results Cancer Res       Date:  2014

8.  Kaposi's sarcoma-associated herpesvirus K7 protein targets a ubiquitin-like/ubiquitin-associated domain-containing protein to promote protein degradation.

Authors:  Pinghui Feng; Christopher W Scott; Nam-Hyuk Cho; Hiroyuki Nakamura; Young-Hwa Chung; Mervyn J Monteiro; Jae U Jung
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation.

Authors:  Elsa-Noah N'Diaye; Kimberly K Kajihara; Ivy Hsieh; Hiroshi Morisaki; Jayanta Debnath; Eric J Brown
Journal:  EMBO Rep       Date:  2009-01-16       Impact factor: 8.807

10.  Characterization of the wheat endosperm transfer cell-specific protein TaPR60.

Authors:  Nataliya Kovalchuk; Jessica Smith; Margaret Pallotta; Rohan Singh; Ainur Ismagul; Serik Eliby; Natalia Bazanova; Andrew S Milligan; Maria Hrmova; Peter Langridge; Sergiy Lopato
Journal:  Plant Mol Biol       Date:  2009-06-10       Impact factor: 4.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.